Optimizing Clinical Trials for Commercial Success

In the planning and design of clinical trials, a little foresight goes a long way. While your compound’s approval may be years away, it’s critical to consider early in the trial planning process how health technology assessments (HTAs) and payers will ultimately impact your compound’s pricing and reimbursement levels when it’s time for commercial launch. By incorporating these elements in your trial design process, you can avoid potential obstacles when your drug is ready for approval.

This webinar focuses on optimizing market access by integrating HTA and payer perspectives in development planning while preserving trial efficiency.

To watch the webinar, please complete the form below. Fields marked with * are required.


Pharmaceutical Product Development, LLC and its affiliates (together “PPD”) will use the information you provide on this page for the purpose of contacting you on this subject. Important information on how PPD handles personal data and what rights you may have under data privacy laws are included within PPD’s Global Privacy Policy.

Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2020 PPD, Inc. All Rights Reserved.